Jonathan Slonin, Chief Medical Officer at Pacira BioSciences, Inc. (PCRX), sold 1,250 shares at $20.05 ($25K) on 2024-08-02, disclosed to the SEC on 2024-08-02.
Scheduled sale ($25k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.75 | 305 | $6K | 25.0% |
| 2 | $20.05 | 945 | $19K | 75.0% |
| Total | $20.22 avg | 1,250 | $25K | 100% |
| Filing → |
| PCRX | SELL | 2025-11-19 | $191K | — | Filing → |
| PCRX | SELL | 2025-01-06 | $16K | — | Filing → |
| PCRX | SELL | 2024-07-03 | $80K | — | Filing → |